Although our data suggest that IL-34 and CD68+ TAM might be useful biomarkers in gastric cancer, other factors, for example, Epstein–Barr virus infection, are well known to be linked with gastric cancer [42]. This evidence concerns the gene IL34 and gastric cancer.